MB
Mohit Bansal Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
45
Avg Return
Past Year
Past Year
5.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
50%
Neutral
50%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $250 |
32%
upside
| 1 | +5.4% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Equal-Weight
Maintained
| $75 |
7%
upside
| 1 | – |
–
| 19 Feb ‘26 13 days ago |
|
|
|
Equal-Weight
Maintained
| $375 |
1%
downside
| 2 | +5.8% |
0
%
| 19 Feb ‘26 13 days ago |
|
|
|
Overweight
Maintained
| $75 |
24%
upside
| 1 | +7.3% |
0
%
| 18 Feb ‘26 14 days ago |
|
|
|
Overweight
Maintained
| $175 |
31%
upside
| 1 | +8.4% |
0
%
| 13 Feb ‘26 19 days ago |
|
|
|
Overweight
Maintained
| $165 |
11%
upside
| 2 | +7% |
0
%
| 11 Feb ‘26 21 days ago |
|
|
|
Equal-Weight
Maintained
| $200 |
5%
upside
| 2 | – |
–
| 9 Feb ‘26 23 days ago |
|
|
|
Equal-Weight
Maintained
| $60 |
4%
downside
| 2 | – |
–
| 6 Feb ‘26 26 days ago |
|
|
|
Overweight
Maintained
| $1,280 |
28%
upside
| 2 | +3.7% |
0
%
| 5 Feb ‘26 27 days ago |
|
|
|
Overweight
Maintained
| $135 |
12%
upside
| 1 | +11% |
0
%
| 4 Feb ‘26 28 days ago |
|
|
|
Equal-Weight
Maintained
| $800 |
2%
upside
| 2 | +6.4% |
0
%
| 2 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $5 |
34%
upside
| 1 | – |
–
| 5 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $8 |
385%
upside
| 1 | +3.8% |
0
%
| 16 Dec ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $515 |
8%
upside
| 1 | +13% |
0
%
| 10 Dec ‘25 2 months ago |
|